What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy

Int J Radiat Oncol Biol Phys. 1999 Jul 1;44(4):747-8. doi: 10.1016/s0360-3016(99)00024-3.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Brachytherapy / methods*
  • Cell Division
  • Cell Survival
  • Dose Fractionation, Radiation
  • Humans
  • Interphase / radiation effects
  • Male
  • Prostate-Specific Antigen / blood
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / radiotherapy*

Substances

  • Prostate-Specific Antigen